Sign in:
 Email
 Password  save:
  
 Company Reports 
 
 
Membership is free, please Sign Up.
  
My Recent Searches
  Help
  
   
 
 
Get Insiders for : 
Bluebird Bio, Inc. (BLUE)  
$1.06 0.06 (5.36%) as of 4:30 Fri 5/10


Download
   
Exchange: N/A
Security Type: Common
Shares Out: 139,126,000
Market Cap: 147.47(M)
Last Volume: 0 Avg Vol: 0
52 Week Range: $0.8871 - $4.83
Level I Sector: Health Care
Level II Sector: Drugs
Level III Sector: Biotechnology

Member Indexes:
   

Rankings:
     
Insider 3 Months    :   -
Insider 6 Months    :   -
Insider 3/6 Months :   -
Guru Rank Number :  -
Guru Rank Value     :  -
Guru Occurances    :  -

 

            6 Months   1 Year   2 Year  
 
Company Profile   bluebird bio is a company focused on the pursuit of curative gene therapies for severe genetic diseases. Co. has late-stage clinical and research programs for the treatment of sickle cell disease (SCD), ss-thalassemia and cerebral adrenoleukodystrophy and is developing research to apply new technologies to these and other diseases. Using a proprietary lentiviral vector platform, Co. custom designs each of its therapies to address the underlying cause of disease by introducing a functional copy of a gene to patients' own isolated hematopoietic stem cells. Co. is developing lovotibeglogene autotemcel as a one-time treatment for patients with SCD.

 
 
Summary  (Direct Transactions Only) 3 Months 6 Months 12 Months 24 Months
Total Shares Bought 0 0 0 0
Total Buy Value $0 $0 $0 $0
Total People Bought 0 0 0 0
Total Buy Transactions 0 0 0 0
Total Shares Sold 17,438 35,533 57,514 116,582
Total Sell Value $26,639 $61,294 $139,194 $443,003
Total People Sold 3 5 5 9
Total Sell Transactions 3 9 12 23
End Date 2024-02-11 2023-11-10 2023-05-12 2022-05-12

   
Records found: 939
  Page 14 of 38  
Filer's Name Relation Title Off-Dir-10% Tran. Date Form Action Price Mkt Value D/I Shares Holdings
Rank

  
3m +/-  
Form
   Davidson David Chief Medical Officer   •       –      –    2019-01-02 4 OE $5.50 $130,410 D/D 7,500 29,605     -
   Wentworth Kory James Principal Accounting Officer   •       –      –    2018-12-19 4 S $103.05 $39,983 D/D (388) 4,612     -
   High Susanna Gatti Chief Operating Officer   •       –      –    2018-12-06 4/A AS $104.13 $198,198 D/D (1,875) 13,750     -
   High Susanna Gatti Chief Operating Officer   •       –      –    2018-12-06 4/A OE $68.65 $1,030 D/D 15 15,625     -
   High Susanna Gatti Chief Operating Officer   •       –      –    2018-12-06 4 AS $104.13 $198,198 D/D (1,875) 13,735     -
   Gregory Philip D Chief Scientific Officer   •       –      –    2018-12-06 4 AS $106.49 $90,577 D/D (850) 30,621     -
   Gregory Philip D Chief Scientific Officer   •       –      –    2018-12-06 4 OE $50.51 $30,306 D/D 600 31,471     -
   Davidson David Chief Medical Officer   •       –      –    2018-12-04 4 AS $120.00 $242,108 D/D (2,000) 24,905     -
   Davidson David Chief Medical Officer   •       –      –    2018-12-04 4 OE $5.50 $11,001 D/D 2,000 26,905     -
   Davidson David Chief Medical Officer   •       –      –    2018-12-03 4 AS $113.59 $681,538 D/D (6,000) 24,905     -
   Davidson David Chief Medical Officer   •       –      –    2018-12-03 4 OE $5.50 $33,002 D/D 6,000 30,905     -
   High Susanna Gatti Chief Operating Officer   •       –      –    2018-12-03 4 S $113.83 $215,135 D/D (1,890) 15,610     -
   Walsh Jeffrey T. Chief Financialand Strategy Of   •       –      –    2018-11-09 4 AS $129.12 $195,891 D/D (1,500) 35,495     -
   Walsh Jeffrey T. Chief Financialand Strategy Of   •       –      –    2018-11-09 4 OE $24.47 $36,705 D/D 1,500 36,995     -
   Gregory Philip D Chief Scientific Officer   •       –      –    2018-11-05 4 AS $136.49 $247,277 D/D (1,800) 30,871     -
   Gregory Philip D Chief Scientific Officer   •       –      –    2018-11-05 4 OE $50.51 $83,226 D/D 1,300 32,671     -
   Davidson David Chief Medical Officer   •       –      –    2018-11-02 4 AS $128.30 $668,216 D/D (5,000) 24,905     -
   Davidson David Chief Medical Officer   •       –      –    2018-11-02 4 OE $5.50 $27,502 D/D 5,000 29,905     -
   Walsh Jeffrey T. Chief Financialand Strategy Of   •       –      –    2018-10-10 4 AS $134.95 $202,839 D/D (1,500) 35,495     -
   Walsh Jeffrey T. Chief Financialand Strategy Of   •       –      –    2018-10-10 4 OE $24.47 $36,705 D/D 1,500 36,995     -
   Gregory Philip D Chief Scientific Officer   •       –      –    2018-10-05 4 AS $139.85 $253,000 D/D (1,800) 31,371     -
   Gregory Philip D Chief Scientific Officer   •       –      –    2018-10-05 4 OE $50.51 $83,226 D/D 1,300 33,171     -
   Davidson David Chief Medical Officer   •       –      –    2018-10-02 4 AS $139.26 $696,588 D/D (5,000) 24,905     -
   Davidson David Chief Medical Officer   •       –      –    2018-10-02 4 OE $5.50 $27,502 D/D 5,000 29,905     -
   Walsh Jeffrey T. Chief Financialand Strategy Of   •       –      –    2018-09-10 4 AS $149.22 $225,243 D/D (1,500) 35,495     -
  939 Records found
  Previous  10  11  12  13  14  15  16  17  18  19  Next   
  Page 14 of 38
  Transaction Code Key: Ownership Code Key
  B - Buy AB - Automatic Buy D - Direct Ownership
  S - Sell AS - Automatic Sell I - Indirect Ownership
  OE - Options Exercised A - Acquired
  IO - Initital Ownership D - Disposed
 
 
    Copyright © 2024 j3sg.com | Disclaimer & Terms of use          Products & Service  About Us  Contact Us